Emergent Biosolutions
EBS
EBS
122 hedge funds and large institutions have $91.6M invested in Emergent Biosolutions in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 47 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
36% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 33
38% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 47
Holders
122
Holding in Top 10
–
Calls
$1.12M
Puts
$528K
Top Buyers
| 1 | +$4.83M | |
| 2 | +$3.23M | |
| 3 | +$1.96M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$1.52M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.33M |
Top Sellers
| 1 | -$5.92M | |
| 2 | -$3.95M | |
| 3 | -$3.04M | |
| 4 |
Morgan Stanley
New York
|
-$2.98M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.5M |